GF Fund Management CO. LTD. acquired a new stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 1,452 shares of the company's stock, valued at approximately $423,000.
Several other institutional investors and hedge funds have also added to or reduced their stakes in MOH. Wellington Management Group LLP lifted its stake in shares of Molina Healthcare by 7.4% in the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after acquiring an additional 181,073 shares during the last quarter. FMR LLC grew its position in shares of Molina Healthcare by 31.1% in the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after buying an additional 427,276 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Molina Healthcare by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock valued at $417,144,000 after purchasing an additional 34,992 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Molina Healthcare by 28.5% during the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock worth $386,229,000 after buying an additional 294,180 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Molina Healthcare by 15.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 688,245 shares of the company's stock worth $200,307,000 after purchasing an additional 91,229 shares in the last quarter. Institutional investors own 98.50% of the company's stock.
Analysts Set New Price Targets
MOH has been the topic of a number of recent analyst reports. Truist Financial lifted their price target on Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Sanford C. Bernstein started coverage on shares of Molina Healthcare in a report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 target price on the stock. Baird R W downgraded Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Barclays lifted their price target on Molina Healthcare from $339.00 to $362.00 and gave the company an "equal weight" rating in a research report on Friday, April 25th. Finally, UBS Group dropped their price objective on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Nine investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, Molina Healthcare currently has a consensus rating of "Hold" and a consensus target price of $365.38.
View Our Latest Analysis on Molina Healthcare
Molina Healthcare Stock Performance
NYSE MOH traded down $6.86 during trading hours on Wednesday, hitting $300.91. The company's stock had a trading volume of 666,511 shares, compared to its average volume of 693,123. The company has a market cap of $16.31 billion, a P/E ratio of 14.73, a price-to-earnings-growth ratio of 1.06 and a beta of 0.63. The company's 50 day simple moving average is $323.92 and its two-hundred day simple moving average is $307.54. Molina Healthcare, Inc. has a 12 month low of $262.32 and a 12 month high of $365.23. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The business had revenue of $11.15 billion for the quarter, compared to the consensus estimate of $10.86 billion. During the same period last year, the firm earned $5.73 earnings per share. The company's quarterly revenue was up 12.2% on a year-over-year basis. As a group, sell-side analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.
Insider Activity at Molina Healthcare
In other Molina Healthcare news, Director Richard M. Schapiro sold 669 shares of the stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director now directly owns 11,244 shares of the company's stock, valued at approximately $3,603,702. This represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. This trade represents a 5.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 89,169 shares of company stock valued at $28,520,995. 1.10% of the stock is owned by company insiders.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.